Analysis of type T1 and T2 cytokines in patients with prostate cancer

被引:2
|
作者
Filella, X
Alcover, J
Zarco, MA
Beardo, P
Molina, R
Ballesta, AM
机构
[1] Hosp Clin Barcelona, Canc Res Unit, Dept Clin Biochem, Inst Invest Biomed August Pi I Sunyer, Barcelona 08036, Spain
[2] Hosp Clin Barcelona, Dept Urol, Inst Invest Biomed August Pi I Sunyer, Barcelona 08036, Spain
来源
PROSTATE | 2000年 / 44卷 / 04期
关键词
prostate cancer; cytokine; Th1-Th2; paradigm;
D O I
10.1002/1097-0045(20000901)44:4<271::AID-PROS2>3.0.CO;2-G
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. It has been proposed that a dysregulation in the balance between type T1 (IL-2, IFN-gamma) and type T2 (IL-4, IL-10) cytokines may be implicated in the development of cancer. METHODS. We determined the expression of IL-2, IL-4, IL-10, and IFN-gamma in CD4 and CD8 lymphocytes by flow cytometry in 12 patients with prostate cancer and in 7 healthy subjects. In addition to the basal expression of these cytokines, their expression was also determined, following stimulation of lymphocytes with PMA (phorbol 12-mystirate 13 acetate) and ionomycin. RESULTS. The basal expression of cytokines was scarce, while following stimulation this increased markedly. On the other hand, there was a dysregulation in the balance between T1 and T2 lymphocytes in patients with prostate cancer. To this effect, in relation to healthy subjects, we observed an increase in IL-10 expression and a decrease in IL-2 expression. CONCLUSIONS. The disequilibrium observed in the balance between type T1 and type T2 cytokines may be implicated in the evolution of neoplastic disease. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:271 / 274
页数:4
相关论文
共 50 条
  • [1] Different basal expression of type T1 and T2 cytokines in peripheral lymphocytes of patients with adenocarcinomas and benign hyperplasia of the prostate
    Elsässer-Beile, U
    Gierschner, D
    Jantscheff, P
    Schultze-Seemann, W
    Katzenwadel, A
    Wetterauer, U
    [J]. ANTICANCER RESEARCH, 2003, 23 (5A) : 4027 - 4031
  • [2] Management of the neck in patients with T1 and T2 cancer in the mouth
    Smith, GI
    O'Brien, CJ
    Clark, J
    Shannon, KF
    Clifford, AR
    McNeil, EB
    Gao, K
    [J]. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2004, 42 (06): : 494 - 500
  • [3] Role of T1 and T2 cytokines in the response to Mycobacterium tuberculosis
    Flynn, JL
    Bloom, BR
    [J]. INERLEUKIN 12: CELLULAR AND MOLECULAR IMMUNOLOGY OF AN IMPORTANT REGULATORY CYTOKINE, 1996, 795 : 137 - 146
  • [4] Morbidity adapted therapy of localised prostate cancer (stage T1 and T2)
    Brookman-Amissah, S.
    Klotz, T.
    Hofstaedter, F. .
    Gerken, M.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 301 - 301
  • [5] Influencing factors for mortality in prostate cancer patients with T1 and T2 stage: a retrospective cohort study
    Hong, Xuwei
    Cao, Sizhe
    Chi, Zepai
    Zhang, Yuanfeng
    Lin, Tianxin
    Zhang, Yonghai
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2023, 12 (01) : 58 - 70
  • [6] Outcomes of radiotherapy in patients with glottic larynx cancer T1 and T2
    Jesús M Flores
    Maria A Poitevín
    Luis F Oñate
    [J]. BMC Cancer, 7 (Suppl 1)
  • [7] Does human toxoplasmosis involve an imbalance in T1/T2 cytokines?
    Marin, JEG
    Pinon, JM
    Bonhomme, A
    Guenounou, M
    [J]. MEDICAL HYPOTHESES, 1997, 48 (02) : 161 - 169
  • [8] PERINEAL VERSUS RETROPUBIC RADICAL PROSTATECTOMY FOR T1, T2 PROSTATE-CANCER
    HAAB, F
    BOCCONGIBOD, L
    DELMAS, V
    BOCCONGIBOD, L
    TOUBLANC, M
    [J]. BRITISH JOURNAL OF UROLOGY, 1994, 74 (05): : 626 - 629
  • [9] BETWEEN T1 AND T2
    WILANSKY, A
    [J]. AMERICAN MATHEMATICAL MONTHLY, 1967, 74 (03): : 261 - &
  • [10] Accelerated radiotherapy for T1 to T2 glottic cancer
    Motegi, Atsushi
    Kawashima, Mitsuhiko
    Arahira, Satoko
    Zenda, Sadamoto
    Toshima, Masamichi
    Onozawa, Masakatsu
    Hayashi, Ryuichi
    Akimoto, Tetsuo
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (04): : 579 - 584